Moderna said Thursday that its vaccine is 93% effective through six months after receiving the second dose. In a news release, the company added that it tested three booster shots in phase 2 of its ...
The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2. The vaccine is not a ...
The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results